Ovarian Cancer Coverage from Every Angle

Long Noncoding RNAs in a Risk Score System for Ovarian Cancer

By: Melissa E. Fryman, MS
Posted: Tuesday, July 23, 2019

Some long noncoding RNAs seem to be associated with an increased risk of ovarian cancer and may have potential as prognostic biomarkers, according to a bioinformatics study by Qian Zhao, PhD, and Conghong Fan, of the Chengdu Women’s & Children’s Central Hospital, China. Their methodology and findings were published in BMC Medical Genetics. 

In this study, RNA-expression data and clinical information from patients with ovarian cancer were obtained from a public database; The Cancer Genome Atlas, GSE32062, and GSE17260 were used as the training and validation data sets, respectively. A weighed gene co-expression network analysis was used to identify long noncoding RNAs in stable modules associated with ovarian cancer, and a validated risk prediction model was used to assign a risk score to each sample. Gene set enrichment analysis was used to examine relevant pathway associations.

The researchers identified 4 highly stable modules associated with ovarian cancer, and 33 long noncoding RNAs implicated in the progression of ovarian cancer. Of them, five long no-coding RNAs—GAS5, HCP5, PART1, SNHG11, and SNHG5—were identified as the optimal prognosis combination for determining a risk score. Pathway enrichment analysis of their target genes showed an association with cell local adhesion, cancer signaling pathways, JAK-STAT signaling, and endogenous cell receptor interaction.

“The risk score system established in this study could provide a novel reliable method to identify individuals at high risk of [ovarian cancer]. In addition, the five prognostic [long noncoding] RNAs identified here are promising potential prognostic biomarkers that could help to elucidate the pathogenesis of [ovarian cancer],” the authors concluded.

Disclosure: The study authors reported no conflicts of interest.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.